Publisher Correction: Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors

Podobne zapisy

• Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
  od: Chepurny, Oleg G., i wsp.
  Wydane: (2018)
• Diabetes Outfoxed by GLP-1?
  od: Holz, George G., i wsp.
  Wydane: (2005)
• Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP
  od: Chepurny, Oleg G., i wsp.
  Wydane: (2019)
• Correction: Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
  od: Chepurny, Oleg G., i wsp.
  Wydane: (2019)
• Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis
  od: Milliken, Brandon T., i wsp.
  Wydane: (2021)